Company / Interest Expense
Harmony Biosciences Holdings, Inc. Interest Expense History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$14.6M
FY2025
5-year range
$7.4M / $23.8M
FY2021-FY2025
Trend
-16.3%
vs FY2024
Sector context
#22 of 44
Health Care
What the data says
At $15M, Harmony Biosciences Holdings, Inc.'s interest expense ranks #23 of 44 in the Health Care sector. Improved from $24M to $15M over the past 2 years.
Based on SEC 10-K filings.
$15M in FY2025 with a 3-year CAGR of -8.0%.
Improved from $24M to $15M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -8.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#23 of 44 in Health CareTop 50% of 44This company $14.6M Sector average $291.0M
▼
-95.0% below sector average
Key checks
Key Insights
- 3-year CAGR of -8.0%, indicating a declining trend.
- In FY2025, interest expense decreased 16.3% year-over-year.
- Ranks #22 out of 44 companies in the Health Care sector.
- Peak interest expense was recorded in FY2023.
Company context
Key Data Points
- Strong profit margin: 20.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.6M | -16.3% |
| FY2024 | $17.5M | -26.4% |
| FY2023 | $23.8M | +26.4% |
| FY2022 | $18.8M | +155.3% |
| FY2021 | $7.4M | - |
| FY2020 | - | - |
| FY2019 | $7.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026